- About
- People
- Funding
- Research Focus
Research activities within the Department of Intensive Care Medicine at TQEH are a combination of:
- Investigator-initiated studies, including those by advanced trainees as part of the course requirements of the College of Intensive Care Medicine, and intensive care nurses
- Investigator-initiated studies conducted under the auspices of the Australian and New Zealand Intensive Care Society Clinical Trials Group
- Industry-sponsored clinical trials
Areas of research include:
- Sepsis studies
- Observational surveys
- Patient safety
- Nutrition studies
- Outcome studies
- Statistical method reviews
- Pharmacokinetic studies
More details about research being undertaken within the Intensive Care Unit at The Queen Elizabeth Hospital can be found here.
Researchers
-
Professor Sandra Peake
Position: Lead Researcher
Group: Intensive Care Medicine
Phone: +61 8 8222 6463
Email: [email protected]
-
Dr Nikki Yeo
Position: Clinician, Postgraduate student
Group: Intensive Care Medicine
Email: [email protected]
Profile: View profile
Please contact the Lead Researcher Professor Sandra Peake for further information about this research group. Further information about the Intensive Care Unit staff at The Queen Elizabeth Hospital can be found here.
Funding since 2016
| Chief Investigators | Granting Body | Project Title | Type of Grant | Grant Amount | Funding Period |
|---|---|---|---|---|---|
| Peake SL as Chair of the Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group | MRFF | Australasian Resuscitation in Sepsis Evaluation Fluids or Vasopressors in Emergency Department Sepsis Trial (ARISE Fluids) | Project Grant | $2,335,540 | 2020-2021 |
| Chapman M, Peake SL, Dean A, O’Connor | NHMRC (#1078026) | The Augmented versus Routine approach to Giving Energy Trial (TARGET) | Project Grant | $3,696,854 | 2015 - 2019 |
| Roberts JA, Lipman J, Peake S, Turnidge J, Slavin M, Hopkins P, Bulitta J, Paul S, De Waele J, Joynt G | NHMRC (#1099452) | Centre for REdefining antibiotic use to reDUce resistanCE and prolong the lives of antibiotics (REDUCE) | Centres of Research Excellence - Clinical | $2,158,296 | 2016 - 2020 |
| Lipman J, Roberts J, Myburgh J, Peake SL, Dulhunty J, Paterson D, McGuinness S, Rhodes A, De Waele J, Finfer S | NHMRC (#1121481) | BLING III: A phase III randomised controlled trial of continuous beta-lactam infusion compared with intermittent beta-lactam dosing in critically ill patients | Project Grant | $3,269,943 | 2017 - 2021 |
| Keijzers G, McDonald S, Williams J, Fraser J, Peake S, Delaney A, Taylor D, Jones P, Williams P | Emergency Medicine Foundation | Fluid resuscitation in emergency patients with sepsis and hypotension | Queensland Research Program | $96,018 | 2018 - 2019 |
Our research focuses on:
• Improving patient safety and outcomes
• Answering pragmatic, relevant clinical questions that are of importance to the clinicians who provide patient care
• Advancements in the delivery of more efficient and effective treatments in the ICU that will not only benefit patients but also decrease costs, preserve resources and increase access to scarce critical care beds
• Statistical analysis of short and long-term outcomes relating to Intensive Care
